| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 52.5219 | 55 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.4517 | 47 |
| GSM780709 | Untreated after 4 days (C3_1) | 49.0322 | 45 |
| GSM780719 | Untreated after 4 days (C1_2) | 58.4457 | 63 |
| GSM780720 | Untreated after 4 days (C2_2) | 48.8683 | 45 |
| GSM780721 | Untreated after 4 days (C3_2) | 48.153 | 42 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 53.2114 | 57 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.4338 | 50 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 53.5959 | 57 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.1565 | 23 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 55.2697 | 60 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.2673 | 38 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 49.8869 | 48 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.6723 | 25 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.0259 | 45 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 54.5617 | 59 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 51.9382 | 54 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.382 | 29 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 54.3997 | 59 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 48.7143 | 44 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.3568 | 46 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 53.3981 | 57 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.1197 | 42 |